How many studies have been conducted on Thromboxane A2?

BiohacksAI has indexed 300 PubMed studies on Thromboxane A2, including 1 randomized controlled trials (RCTs). 10% of studies involve human subjects.

What are the main research areas for Thromboxane A2?

The primary research domains for Thromboxane A2 are 🔬 Inflammation, ❤️ Cardiovascular, 🦴 Bone & Joint. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Thromboxane A2

An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS).

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 45.6

Research Domains

Thromboxane A2 has been studied across 17 research domains including 🔬 Inflammation, ❤️ Cardiovascular, 🦴 Bone & Joint, 🫁 Respiratory, 🫘 Kidney. The primary research focus is 🔬 Inflammation with 55% of studies addressing this area.

Loading evidence profile...

This evidence profile for Thromboxane A2 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.